Down-Regulation of Multiple Low Dose Streptozotocin-Induced Diabetes by Mycophenolate Mofetil

Clinical and Experimental Immunology- United Kingdom

doi 10.1046/j.1365-2249.2002.02001.x

Full Text

Abstract

Available in

Date

Authors

Publisher

Wiley

Related search

Taenia crassicepsInfection Attenuates Multiple Low-Dose Streptozotocin-Induced Diabetes

Journal of Biomedicine and Biotechnology
2010Spanish

Low Dose of Mycophenolate Mofetil Is Enough in Desensitized Kidney Transplantation Using Rituximab

BMC Nephrology
Nephrology
2015English

134 Impact of Combined Mycophenolate Mofetil and Low Dose Calcineurin Inhibitor Therapy on T Cell Function

Journal of Hepatology
Hepatology
2006English

Mycophenolate Mofetil for Drug-Induced Vanishing Bile Duct Syndrome

World Journal of Gastroenterology
MedicineGastroenterology
2007Danish

Low-Dose Mycophenolate Mofetil for Treatment of Neuromyelitis Optica Spectrum Disorders: A Prospective Multicenter Study in South China

Frontiers in Immunology
AllergyImmunology
2018English

Mycophenolate Mofetil Induced Remission in Steroid-Refractory Autoimmune Hemolytic Anemia

Meandros Medical and Dental Journal
2018English

Immunosuppression of Experimental Autoimmune Myasthenia Gravis by Mycophenolate Mofetil

Journal of Neuroimmunology
AllergyImmunologyNeurology
2008English

Vancomycin Relieves Mycophenolate Mofetil–induced Gastrointestinal Toxicity by Eliminating Gut Bacterial Β-Glucuronidase Activity

Science advances
Multidisciplinary
2019English

Multiple Low-Dose Streptozotocin-Induced Diabetes in the Mouse: Further Evidence for Involvement of an Anti-B Cell Cytotoxic Cellular Auto-Immune Response

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1987English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy